Tiffany E. Kaiser

419 total citations
13 papers, 328 citations indexed

About

Tiffany E. Kaiser is a scholar working on Hepatology, Epidemiology and Transplantation. According to data from OpenAlex, Tiffany E. Kaiser has authored 13 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 7 papers in Epidemiology and 7 papers in Transplantation. Recurrent topics in Tiffany E. Kaiser's work include Renal Transplantation Outcomes and Treatments (7 papers), Liver Disease and Transplantation (6 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Tiffany E. Kaiser is often cited by papers focused on Renal Transplantation Outcomes and Treatments (7 papers), Liver Disease and Transplantation (6 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Tiffany E. Kaiser collaborates with scholars based in United States. Tiffany E. Kaiser's co-authors include Nyingi Kemmer, Guy Neff, Shimul A. Shah, Tayyab S. Diwan, Kamran Safdar, Madison C. Cuffy, Nadeem Anwar, E. Steve Woodle, Ralph C. Quillin and Khurram Bari and has published in prestigious journals such as Transplantation, Journal of the American College of Surgeons and Digestive Diseases and Sciences.

In The Last Decade

Tiffany E. Kaiser

12 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tiffany E. Kaiser United States 10 237 209 185 72 32 13 328
Hussien Elsiesy Saudi Arabia 11 227 1.0× 174 0.8× 168 0.9× 27 0.4× 23 0.7× 37 343
A.D. Pinna Italy 10 119 0.5× 119 0.6× 189 1.0× 62 0.9× 25 0.8× 17 344
Guido Cantisani Brazil 11 245 1.0× 172 0.8× 192 1.0× 85 1.2× 8 0.3× 19 319
Khurram Bari United States 13 342 1.4× 295 1.4× 183 1.0× 72 1.0× 19 0.6× 22 441
Imre Fehérvári Hungary 10 193 0.8× 126 0.6× 220 1.2× 52 0.7× 12 0.4× 66 339
Jennifer T. Wells United States 8 270 1.1× 225 1.1× 64 0.3× 44 0.6× 34 1.1× 15 352
Nikhil Kapila United States 7 148 0.6× 81 0.4× 82 0.4× 134 1.9× 26 0.8× 22 264
Prowpanga Udompap United States 9 253 1.1× 276 1.3× 46 0.2× 21 0.3× 13 0.4× 22 341
Sumeyye Samur United States 9 263 1.1× 243 1.2× 84 0.5× 25 0.3× 10 0.3× 15 321
Ignacio García‐Juárez Mexico 10 179 0.8× 150 0.7× 97 0.5× 18 0.3× 41 1.3× 50 295

Countries citing papers authored by Tiffany E. Kaiser

Since Specialization
Citations

This map shows the geographic impact of Tiffany E. Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiffany E. Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiffany E. Kaiser more than expected).

Fields of papers citing papers by Tiffany E. Kaiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiffany E. Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiffany E. Kaiser. The network helps show where Tiffany E. Kaiser may publish in the future.

Co-authorship network of co-authors of Tiffany E. Kaiser

This figure shows the co-authorship network connecting the top 25 collaborators of Tiffany E. Kaiser. A scholar is included among the top collaborators of Tiffany E. Kaiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiffany E. Kaiser. Tiffany E. Kaiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Delman, Aaron M., Khurram Bari, Tiffany E. Kaiser, et al.. (2025). Friend or Foe? Safety and Efficacy of Hepatitis B Viremic Solid Organ Allograft into Seronegative Recipients. Journal of the American College of Surgeons. 240(4). 449–459.
2.
Choi, David, Tiffany E. Kaiser, Karen Khalil, et al.. (2022). The use of non‐transplant biologics in solid organ transplant recipients: A practical review for the frontline clinician. Clinical Transplantation. 36(7). e14743–e14743. 3 indexed citations
3.
Anwar, Nadeem, Tiffany E. Kaiser, Khurram Bari, et al.. (2020). Use of Hepatitis C Nucleic Acid Test–Positive Liver Allografts in Hepatitis C Virus Seronegative Recipients. Liver Transplantation. 26(5). 673–680. 12 indexed citations
4.
Jorgenson, Margaret R., et al.. (2020). Alternatives to immediate release tacrolimus in solid organ transplant recipients: When the gold standard is in short supply. Clinical Transplantation. 34(7). e13903–e13903. 6 indexed citations
5.
Cuffy, Madison C., Tiffany E. Kaiser, John Cafardi, et al.. (2019). Use of HCV Ab+/NAT− donors in HCV naïve renal transplant recipients to expand the kidney donor pool. Clinical Transplantation. 33(7). e13598–e13598. 18 indexed citations
6.
Morris, Mackenzie C., Andrew D. Jung, Young Kim, et al.. (2019). Delayed Sleeve Gastrectomy Following Liver Transplantation: A 5‐Year Experience. Liver Transplantation. 25(11). 1673–1681. 25 indexed citations
7.
Kaiser, Tiffany E., Khurram Bari, Kamran Safdar, et al.. (2018). Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients. Journal of the American College of Surgeons. 228(4). 560–567. 28 indexed citations
8.
Singhal, Ashish, Gregory C. Wilson, Koffi Wima, et al.. (2014). Impact of recipient morbid obesity on outcomes after liver transplantation. Transplant International. 28(2). 148–155. 67 indexed citations
9.
Neff, Guy, et al.. (2010). Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series. Liver Transplantation. 16(8). 960–963. 28 indexed citations
10.
Kemmer, Nyingi, et al.. (2008). Liver Transplantation Trends for Older Recipients: Regional and Ethnic Variations. Transplantation. 86(1). 104–107. 21 indexed citations
11.
Kemmer, Nyingi, et al.. (2008). Impact of Geographic Location on Access to Liver Transplantation Among Ethnic Minorities. Transplantation. 85(2). 166–170. 25 indexed citations
12.
Kemmer, Nyingi, et al.. (2008). Access to Liver Transplantation in the MELD Era: Role of Ethnicity and Insurance. Digestive Diseases and Sciences. 54(8). 1794–1797. 46 indexed citations
13.
Neff, Guy, Nyingi Kemmer, Tiffany E. Kaiser, et al.. (2006). Analysis of Hospitalizations Comparing Rifaximin Versus Lactulose in the Management of Hepatic Encephalopathy. Transplantation Proceedings. 38(10). 3552–3555. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026